Abstract
In mammalian cells, 5-methylcytosine (5mC) occurs in genomic double-stranded DNA (dsDNA) and is enzymatically oxidized to 5-hydroxymethylcytosine (5hmC), then to 5-formylcytosine (5fC), and finally to 5-carboxylcytosine (5caC). These cytosine modifications are enriched in regulatory regions of the genome. The effect of these oxidative products on five bZIP dimers (CREB1, ATF2, Zta, ATF3|cJun, and cFos|cJun) binding to five types of dsDNA was measured using protein binding microarrays. The five dsDNAs contain either cytosine in both DNA strands or cytosine in one strand and either 5mC, 5hmC, 5fC, or 5caC in the second strand. Some sequences containing the CEBP half-site GCAA are bound more strongly by all five bZIP domains when dsDNA contains 5mC, 5hmC, or 5fC. dsDNA containing 5caC in some TRE (AP-1)-like sequences, e.g., TGACTAA, is better bound by Zta, ATF3|cJun, and cFos|cJun.
Graphical Abstract

Transcription factors (TFs) bind sequence-specific dsDNA and regulate gene expression.1,2 The question of dsDNA binding specificity has become more complex in mammals with the observation that 5mC that occurs in the genome is iteratively oxidized by the ten-eleven-translocation (TET) family of dioxygenases to 5-hydroxymethylcytosine (5hmC),3 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC).4 5fC and 5caC are replaced with cytosine by thymine DNA glycosylase, completing the cytosine demethylation cycle.5,6
These cytosine modifications occur in regulatory regions of the genome7–11 and change through development and pathology.12 5mC is particularly enriched at CG dinucleotides but is known to occur outside of CG dinucleotides in stem cells and brain.13,14 5hmC enrichment occurs in embryonic stem cells (ESCs),3 neural cells,15 primordial germ cells,16 fertilized oocytes,17 and tumor cells.18 5fC is present at levels similar to those of 5mC and 5hmC at specific genomic sites, e.g., poised or active enhancers7 and some exons.19,20 5caC is enriched at some major satellite repeats.21 In some pathogeneses and cancers, like myeloid malignancies, this demethylation pathway is misregulated.22 Several groups have used various methods to identify proteins that preferentially bind modified dsDNA,23–29 but the biological importance of this preferential binding is difficult to determine.
5mC can both inhibit and enhance the binding of TFs to specific dsDNA sequences.23,30–34 Our previous work using PBMs has shown that cytosine methylation outside of CG dinucleotides can dramatically alter sequence-specific DNA binding of Tcf3|Ascl1,35 CREB1,36 and Zta.37 Examination of the effect of the oxidative products of 5mC on sequence-specific TF binding to dsDNA is a new endeavor. The three 5mC oxidative products can change sequence-specific binding of TFs.28,35,38,39
bZIP proteins are eukaryotic TFs that bind sequence-specifically to dsDNA as homodimers or heterodimers.40,41 The bZIP domain is a long bipartite α-helix.42,43 The C-terminus contains an amphipathic α-helix that can homodimerize and/or heterodimerize to form a leucine zipper coiled coil.40,43,44 The N-terminal basic region lies in the major groove of dsDNA and binds sequence-specifically with each monomer binding one half-site of the often-palindromic motif.43 The dsDNA binding specificity of each bZIP dimer is determined by specific residues in the α-helical basic region45 that differ between subclasses of bZIP proteins.43,46
Five amino acid residues of the bZIP protein directly contact DNA nucleotides.47,48 These include conserved consecutive alanines that interact with the methyl groups of two thymines at T2 and T−4 49 in the canonical CRE (T−4G−3A−2C−1G1T2C3A4) and the related TRE (T−4G−3A−2C/G0T2C3A4) that differ by one nucleotide at the center of the motif.50 We used a numbering strategy explaining the nucleotide positions as described previously.37 Our previous work examined how 5mC and 5hmC affected dsDNA binding of Zta, CREB1, CEBPB, and cFos|cJun to specific sequences.36 Methylation of cytosine at C−4 increases the level of binding by 10-fold for the CEBPB|ATF4 heterodimer to C−4GATGC2AA.23 Zta also binds methylated C−4.49 Methylation of cytosine, mimicking the methyl group of thymine, at C2 in GC2AA, the half-site of the canonical CEBP motif, stabilizes binding of many bZIP dimers, including CREB36 and Zta.37 At a structural level, this work highlighted an alanine residue in CREB1, cJun, and cFos, a serine residue in Zta, and a valine in CEBPB explaining the altered DNA binding specificity.37 Mutagenesis experiments that mutated serine 189 in Zta51 and a conserved valine in CEBPB52 highlighted the important roles of these residues in determining the specificity of binding to 5mC and 5hmC. In this study, we examined the effects of 5mC, 5hmC, 5fC, and 5caC in one strand of dsDNA on sequence-specific binding of five bZIP domains (CREB1, ATF2, Zta, ATF3|cJun, and cFos| cJun).
EXPERIMENTAL PROCEDURES
Cloning and Expression of bZIP DNA Binding Domains.
The bZIP DNA binding domains (DBDs) of mouse CREB1, ATF2, cJun, and Epstein-Barr viral protein Zta were obtained from T. Hughes (University of Toronto, Toronto, ON) as a chimeric GST construct. CREB1, ATF2, and cJun were cloned into the pETGEXCT (C-terminal GST) vector.53 Zta was cloned into a modified pDEST15 MAGIC vector (N-terminal GST).53 The DBDs of mouse ATF3 and cFos were obtained as a construct cloned into a pT5 expression plasmid.50 Proteins were expressed using the PURExpress in vitro protein synthesis kit (NEB) according to the manufacturer’s protocol23 in a 25 μL reaction volume containing 180 ng of plasmid. The α-helical dsDNA binding regions of the bZIP domains are aligned. Conserved bZIP domain residues are highlighted in yellow, and the variations in red (Chart 1).
Chart 1.
Design of the 40K Feature Array and PBM Experiments.
The design of the Agilent 40K array has been described previously.23,54–56 Specifically, we used the “HK” array design available on the NCBI Gene Expression Omnibus platform GPL11260 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GPL11260). HK microarrays with 40330 single-stranded DNA 60-mers were double-stranded to generate five types of dsDNA using either cytosine (C, NEB), 5-methylcytosine (5mC, NEB), 5-hydroxymethylcytosine (5hmC, Zymo Research), 5-formylcytosine (5fC, TriLink Biotechnologies), or 5-carboxylcytosine (5caC, TriLink Biotechnologies).28,35,38 The double-stranding efficiency was monitored using either 4% Cy3-dCTP (GE Healthcare)52 or 4× SYBR-Gold (LifeTechnologies Corp.) DNA intercalating dye. These microarrays were used for protein binding microarray (PBM) experiments in which a GST-tagged bZIP DNA binding domain binds to the DNA on the microarray slide. Protein binding reactions were performed as described previously.23,36,51,52 Briefly, 180 ng of plasmid containing DNA binding domains was used to express proteins using the PureExpress in vitro transcription translation kit (NEB) in a 25 μL reaction volume following the manufacturer’s instructions. The double-stranded arrays and in vitro-expressed proteins were blocked with 4% milk and BSA before the binding reaction. The protein binding reactions were carried out in a hydration chamber for 1 h followed by incubation with the Alexa Fluor 647-conjugated anti-GST antibody for 1 h. Finally, array slides were washed, dried, and scanned using an Agilent Sure Scan II microarray scanner to measure the fluorescence intensities of bound proteins.
Image Quantification and Calculation of 8-mer Z Scores.
For each PBM, scanned image quantification and Z score calculation were performed as described previously.38 Microarray images were analyzed using ImaGene (BioDiscovery Inc.), and the extracted data (probe fluorescence intensity values) were used for further analysis. The probe median intensities were used to calculate the Z score for all 65536 8-mers for all other PBM experiments except dsDNA with cytosine in both strands, as complementary 8-mers are different due to the asymmetric nature of the double-stranding protocol for all four cytosine modifications. For these 8-mers, we compute the Z scores of the reverse complement of the 8-mer extracted from the array probe design. Thus, all 8-mers shown and analyzed for these experiments are taken from the strand that can contain 5mC, 5hmC, 5fC, and 5caC. We also note that the PBM design we used contains features in which all 8-mers occur 32 times on the array when double-stranded. For Z score calculations in which complements are not identical, certain 8-mers are rare. For these experiments, we show only Z scores for 8-mers that appear on at least 10 features, eliminating 1148 8-mers. All of the TFs were assayed with at least two replicates, with good agreement (R > 0.8) (Figures S1 and S7). Data (raw probe intensities and 8-mer Z scores) are available at the NCBI GEO database under accession number GSE141050.
Analysis of 8-mers in ChIP-seq Data Sets.
Human ChIP-seq peaks from the ENCODE Web site57,58 (Table S6) were downloaded, and Zta ChIP-seq peak coordinates in Akata cells were obtained.59 For the analysis of bZIP heterodimers, we generated a set of overlapping ATF3|cJun and cFos|cJun ChIP-seq peaks. To determine the enrichment of each 8-mer in a given ChIP-seq data set, we calculated an “enrichment score”, , for each 8-mer across the human genome (UCSC build hg19). OCCobs is the number of observed occurrences in each set of peaks, and OCCexp is the number of expected occurrences of the motif. OCCexp was calculated with the equation , where N is the total number of motifs in the whole genome, Lr is the total length (in base pairs) in the set of peaks, and Lg is the total length (in base pairs) of the human genome.
RESULTS
Protein Binding Microarray with Five Types of dsDNA.
We exploited the property of T7 DNA polymerase to incorporate biologically occurring cytosine modifications into dsDNA.60,61 Cytosine and the four modified cytosines (5mC, 5hmC, 5fC, and 5caC) were used to generate five types of dsDNA on the PBM. The five dsDNAs contain either cytosine in both DNA strands [DNA(C|C)] or cytosine in one strand and either 5mC, 5hmC, 5fC, or 5caC in the second strand [DNA(5mC|C), DNA(5hmC|C), DNA(5fC|C), and DNA(5caC|C)].36,37,56
The progress of elongation on the glass slide of T7 DNA polymerase producing a new ssDNA templated by the ssDNA on the glass slide to form dsDNA was monitored in two ways. One is to incorporate Cy3-dCTP into the newly synthesized ssDNA strand.23 The second method is to use SYBR-Gold, which intercalates into dsDNA.62,63 The histogram of fluorescence intensities at 570 nm for Cy3-dCTP incorporation after the five double-stranding DNA reactions is plotted in Figure 1A, and the average intensities are shown in Figure 1C. Cytosine, 5hmC, and 5fC have similar amounts of Cy3-dCTP fluorescence, with that of 5mC being 2-fold higher. 5caC showed an almost 10-fold higher fluorescence. We divided the fluorescence intensities of each feature by the number of cytosines in the newly synthesized 35-mer variable sequence that incorporates Cy3-dCTP. This analysis indicates that probes with more cytosines have more Cy3-dCTP signal (orange lines in Figure 1A).
Figure 1.

DNA double-stranding efficiency on the PBMs with cytosine, 5mC, 5hmC, 5fC, and 5caC measured by (A and C) Cy3-dCTP incorporation or (B and D) SYBR-Gold binding. In panels A and B, 40300 features are ordered by fluorescence intensity (blue). The orange histogram in panel A shows the fluorescence normalized by cytosine number in the newly made DNA strand (number of guanines in the ssDNA sequence on the microarray). In panels C and D are comparisons of the average fluorescence intensities of 40330 features of ssDNA and five dsDNA with the standard error between two replicates in panel D.
Next, we added SYBR-Gold, which intercalates into dsDNA.63 Histograms of fluorescence intensities for ssDNA and five types of dsDNA were measured at 550 nm (Figure 1B,D). All of the dsDNAs have 4–6 times more fluorescence than ssDNA, suggesting that the modified cytosines were incorporated into dsDNA (Figure 1D). Comparing the Cy3-dCTP and SYBR-Gold data suggests that the T7 DNA polymerase prefers Cy3-dCTP compared to 5caC. Though T7 polymerase did not prefer 5caC, it produced similar amounts of dsDNA as cytosine and the other modified cytosines.
Binding Data Analysis.
dsDNA microarrays were used for protein binding experiments using in vitro-synthesized GST-tagged bZIP domains. Binding is detected by the fluorescence intensity of a Cy5-labeled anti-GST antibody. These fluorescence data were analyzed by three methods. First, we compared the fluorescence intensities of the 40330 features on the microarray for the five types of dsDNA. Each feature on the array contains a different dsDNA 35-mer. Essentially, we are examining sequence-specific dsDNA binding in a nonspecific dsDNA background. Second, we computed a standardized score (Z score) for all possible 8 bp DNA sequences (8-mers) to examine sequence-specific dsDNA binding.55 We focused on features and Z scores that contained either the CEBPB half-site GC2AA or the CRE half-site TGAC‑1 to examine the C2 and C−1 positions in an 8 bp motif. Third, single-nucleotide variant (SNV) tables were generated for several 8-mers, including a non-cytosine-containing 8-mer, to examine the contribution of modified cytosines throughout the motif to sequence-specific dsDNA binding.
CREB1 Binding to Five Types of dsDNA.
The binding of CREB1 to three types of dsDNA [DNA(C|C), DNA(5mC|C), and DNA(5hmC|C)] has been examined.36 Binding to the five types of dsDNA was carried out in parallel and yielded results that matched previously published results (Figure S2). We compared binding to normal dsDNA [DNA(C|C)] and each of the four modified dsDNAs to (1) each feature on the PBM (Figure S3A–D), (2) Z scores for all 8-mers (Figure S3E–H), and (3) Z scores for 8-mers with one cytosine to determine the contribution of a single cytosine modification to dsDNA binding (Figure 2A–D). We also examined how each step in the methylation cycle changed binding (Figure S3I–K and Figure 2E–G). Strong binding to some features is observed with all five types of dsDNA. Average and median binding values are presented (Table S1). The greater the difference between average and median binding, the more sequence-specific dsDNA binding is occurring. For example, the difference is greater for CREB1 than for ATF2, suggesting more sequence-specific binding for CREB1.
Figure 2.

CREB1 binding to five types of dsDNA. Z scores for 8-mers with one cytosine for CREB1 binding: (A) dsDNA containing cytosine in both strands DNA(C|C) (x-axis) and DNA(5mC|C) (y-axis), (B) DNA(C|C) (x-axis) and DNA(5hmC|C) (y-axis), (C) DNA(C|C) (x-axis) and DNA(5fC|C) (y-axis), (D) DNA(C|C) (x-axis) and DNA(5caC|C) (y-axis), (E) DNA(5mC|C) (x-axis) and DNA(5hmC|C) (y-axis), (F) DNA(5hmC|C) (x-axis) and DNA(5fC| C) (y-axis), and (G) DNA(C5f|C) (x-axis) and DNA(5caC|C) (y-axis). 8-mers are divided into three groups for panels A–D [8-mers containing the C/EBP half-site GC2AA (green), the CRE half-site TGAC (red), and the rest of the 8-mers (black)] and in five groups for panels E–H [8-mers containing the C/EBP half-site GC2AA (green), the CRE half-site TGAC (red), C−4GAT (blue), the rest of 8-mers with cytosine (black), and 8-mers with no cytosines (gray)].
As observed previously, 5mC and 5hmC strengthen binding to 8-mers with GC2AA and weaken binding to 8-mers with TGAC−136 (Figure 2A,B and Figure S3A,B,E,F). With 5fC, the same trend is observed (Figure 2C). Several 8-mers with multiple cytosines and GC2AA like CCACGC2AA are strongly bound with 5fC (Figure S3C,G). The best bound 8-mer with 5mC, 5hmC or 5fC is TGATGC2AA. CREB1 binds dsDNA with 5caC in one strand similarly or slightly more weakly to dsDNA with cytosine in both strands (Figure 2D and Figure S3D,H). 8-mers containing TGAC−1 and 5caC are better bound compared to 8-mers containing 5mC, 5hmC, and 5fC (Figure 2E–G and Figure S3I–K) but still weaker than cytosine (Figure 2D and Figure S3H).
We next generated single-nucleotide variant (SNV) tables for binding of CREB1 to dsDNA and dsDNA containing 5mC, 5hmC, 5fC, and 5caC in one strand (Table 1). The 8-mers examined include the canonical CRE motif TGAC−1GTC3A containing two cytosines. We also examined 8-mers containing one cytosine to determine the contribution of modified cytosine at different parts of the motif to CREB1 binding strength. We focused on cytosine and its modifications at positions C−1, C2, and C3. These 8-mers are TGATGTC3A, TTAC−1GTAA, TGAC−1GTTA, and TGATGC2AA. We also examined an 8-mer with no cytosines, replacing both cytosines in the canonical CRE with thymine (TGATGTTA). These SNV table results reinforce what we learned from examining Z scores for 8-mers. 5mC, 5hmC, and 5fC facilitate binding at C2 and inhibit binding at C−1. 5caC slightly favors C−1 but not C2.
Table 1.
SNV Tables of Z Scores for the Binding of CREB1 to (A) the Canonical CRE Motif, TGAC−1GTC3A, (B) Variants of CRE Motif TGATGTC3A, (C) PAR Consensus Motif TTAC−1GTAA, (D) Variants of PAR Consensus Motif TGAC−1GTTA, (E) Best Bound Motif TGATGC2AA, and (F) Variants 8-mers TGATGTT3Aa
|
Shaded cells highlight specific substitutions mentioned in the text.
ATF2 Binding to Five Types of dsDNA.
The ATF2 binding fluorescence is approximately half of that observed for CREB1 (Figure S4A–D and Table 1). Figure 3A–D shows ATF2 Z scores for 8-mers containing one cytosine. The best bound 8-mer is the CRE like ATGAC−1GTA. As observed with CREB1, 5mC, 5hmC, and 5fC strengthen the binding to 8-mers containing GC2AA and weaken the binding to 8-mers containing TGAC−1. Binding to 8-mers containing 5caC is similar to that with cytosine. When we examined the change in binding with oxidation, the most dramatic changes are with methylation of cytosine and the change from 5fC to 5caC (Figure 3A,G and Figure S4E,K). 5fC containing 8-mers like TACCGC2AA with multiple cytosines and GC2AA is strongly bound (Figure S4E,G). SNV tables for binding of ATF2 to these five dsDNAs are similar to that of CREB1 (Table S2).
Figure 3.

ATF2 binding to five types of dsDNA. Z scores for 8-mers with one cytosine for ATF2 binding to dsDNA as described in Figure 2.
Zta Binding to Five Types of dsDNA.
The binding of Zta to three types of dsDNA [DNA(C|C), DNA(5mC|C), and DNA(5hmC|C)] has been described.37 We extended those studies by examining 5fC and 5caC in one strand of dsDNA (Figure S5A–H and Figure 4A–D). The preference for 5mC, 5hmC, and 5fC at C2 is stronger than observed for CREB1 and ATF2. 5caC inhibits binding to 8-mers containing GC2AA. Only a few 8-mers with CRE half-site TGAC−1 are bound strongly in the presence of 5caC. Upon examination of the change in Z score with each step in the methylation cycle, 5fC weakens binding to 8-mers containing GC2AA compared to 5hmC (Figure 4E–G). Examination of SNV tables confirms that 5mC, 5hmC, and 5fC are preferred in C2 but not in C−1 (Table S3).
Figure 4.

Zta binding to five types of dsDNA. Z scores for 8-mers with one cytosine for Zta binding to dsDNA as described in Figure 2.
ATF3|cJun Heterodimer Binding to Five Types of dsDNA.
ATF3|cJun binding is not dramatically changed with the cytosine modifications with a few exceptions, particularly for 8-mers with multiple cytosines (Figure 5A–D and Figure S6A–H). Preferential binding to TRE and not the CRE is observed. Several 8-mers with multiple cytosines and TGAC−1 like CATGAC−1GT are strongly bound with 5caC unlike CREB1, ATF2, and Zta (Figure S6H). Next, we examined SNVs of the six 8-mers examined with CREB1 (Table S4). Though Z scores are low, the trends observed at C−1 and C2 for CREB1, ATF2, and Zta are observed. 5mC, 5hmC, and 5fC is favored at C2, and 5caC is not. 5caC is favored at C−1.
Figure 5.

ATF3|cJun binding to five types of dsDNA. Z scores for 8-mers with one cytosine for ATF3|cJun binding to dsDNA as described in Figure 2.
cFos|cJun Binding to Five Types of DNA.
cFos|cJun also preferentially binds the TRE (Figure 6A–D and Figure S7A–H). When Z scores are compared as cytosine becomes methylated and subsequently oxidized (Figure 6A,E–G and Figure S7E,I–K), dsDNA with 5mC showed a moderate binding preference with 8-mers containing GC2AA half-sites with single or multiple cytosines, but only 5fC has a binding preference with 8-mers containing multiple cytosines and GC2AA. SNVs of the six 8-mers examined with CREB1 (Table S5) reinforce our previous observations, similar to ATF3|cJun with strengthened binding for 8-mers containing 5mC, 5hmC, and 5fC at the C2 position, but weakened binding at C−1. 5caC at C−1 is favored, but not at C2.
Figure 6.

cFos|cJun binding to five types of dsDNA. Z scores for 8-mers with one cytosine for cFos|cJun binding to dsDNA as described in Figure 2.
Comparison of bZIP TFs Binding to Five Types of dsDNA.
We summarized the effects of each of the five types of dsDNAs on binding for each of the bZIP proteins examined. Correlation plots of the five bZIP domains binding the five types of dsDNA reveal both similarities and differences between bZIP proteins (Figure 7). Binding to 8-mers containing 5mC, 5hmC, and 5fC is similar for CREB1, Zta, and ATF2 (Figure 7A–C). Correlations between 8-mers containing these modifications are moderate to high (R = 0.48–0.7) and approach correlations obtained for replicate experiments [R = 0.88–1 (Figure 7 and ref 37)]. 8-mers with cytosine or 5caC are bound more similarly by CREB1, Zta, and ATF2 (Figure 7A–C) but less so by ATF3|cJun and cFos|cJun (Figure 7D,E). When we examine binding by dsDNA type, new differences are revealed. Zta does not form groups with other bZIPs for all five dsDNAs (Figure 8), highlighting its distinct properties for binding to DNAs containing modified cytosines as shown previously.37
Figure 7.

Summary of correlations of each bZIP protein binding five types of dsDNA. Summary of Pearson correlations computed using the top 500 8-mer Z scores for (A) CREB1, (B) ATF2, (C) Zta, (D) ATF3|cJun, and (E) cFos|cJun.
Figure 8.

Correlations between TF binding to five types of dsDNA. Summary of Pearson correlations computed for the top 500 8-mers Z scores for CREB1, ATF2, Zta, ATF3|cJun, and cFos|cJun binding to dsDNA (A) (DNA(C|C), (B) DNA(5mC|C), (C) DNA(5hmC|C), (D) DNA(5fC|C), and (E) DNA(5caC|C).
We next generated sequence logos of well-bound 8-mers and examined comparisons of the similarities and differences in the preferences of binding of each bZIP protein to modified DNAs (Figures S8–S11). CREB1 and ATF2 prefer binding the CRE (TGAC−1GTC3A), while Zta, ATF3|cJun, and cFos|cJun prefer the TRE (TGAC/G0TC3A) (Figures S8 and S9). CREB1 more specifically prefers the five types of dsDNA than the four other bZIPs. When binding DNA(C|C), CREB1 binds the canonical CRE sequence more specifically than the all of the other bZIPs while Zta, ATF3|cJun, and cFos|cJun prefer the TRE [TGAC/G0TC3A (Figures S8 and S9B–D)].37 With DNA(5mC|C), all of the bZIPs bind 8-mers with GC2AA, particularly Zta37 (Figures S8 and S9E–H). With DNA(5hmC|C), many new 8-mers are strongly bound. Zta again binds strongly to some 8-mers with GC2AA (Figures S8 and S9I–L). With DNA(5fC|C), the greatest difference is between CREB1 and Zta, which bind strongly to different 8-mers with GC2AA (Figures S8 and S9M–P). With DNA(5caC|C), the bZIP domains strongly bind different 8-mers with TGAC−1 (Figures S8 and S9Q–T). Upon comparison of the binding specificities between DNA(5fC|C) and DNA(5caC|C), correlation plots distinctly segregate the bindings of all five bZIPs TFs into two groups (Figure S1). TFs bind specifically with 8-mers containing GC2AA for 5fC and 8-mers with TGAC−1 for 5caC (Figures S8 and S10).
We compared ATF3|cJun and cFos|cJun binding each type of dsDNA (Figure S11). With DNA(C|C), ATF3|cJun prefers the canonical CRE motif while the cFos|cJun heterodimer prefers TRE (Figure S11A). With DNA(5hmC|C), the heterodimers prefer different types of new 8-mers (Figure S11C), while with DNA(5fC|C), they prefer different 8-mers with GC2AA (Figure S11D). For DNA(5caC|C), both heterodimers prefer similar 8-mers with TGAC−1 with only a few exceptions. For example, ATF3|cJun has a slight binding preference for 8-mers like ACCATGAC−1 or CCATGAC−1A, while cFos|cJun prefers ATGAC−1TAA (Figure S11E).
bZIP-Bound Modified 8-mers Are Enriched in Bound Genomic Locations In Vivo.
We examined publicly available ChIP-seq data to determine whether 8-mers that we identify as being strongly bound when they contain modified cytosines are enriched at bound genomic regions in vivo. For this analysis, we examined a set of strongly bound 8-mers for each TF that are well-bound when they contain any modified cytosine (Table S7, Figure S12, and Experimental Procedures). We find that 8-mers that are well-bound as modified DNAs on our PBMs are enriched in ChIP-seq peaks, suggesting that these 8-mers may function in vivo. In particular, the TGATGC2AA 8-mer, which is well bound by CREB1 and ATF3|cJun when it contains modified cytosine, is >2-fold enriched in all CREB1 and ATF3|cJun peaks examined but is not enriched in Zta ChIP-seq peaks (Figure S12). In contrast, the 8-mer ATGAGC2AA, which is well-bound by Zta as modified DNAs on PBMs, is most highly enriched in Zta ChIP-seq peaks compared to the other bZIP ChIP-seq data sets examined (Figure S12).
DISCUSSION
In this study, we examined the effect of modified cytosines (5mC, 5hmC, 5fC, and 5caC) in one strand of dsDNA on sequence-specific binding of five bZIP dimers (CREB1, Zta, and ATF2 homodimers and ATF3|cJun and cFos|cJun heterodimers). For all five bZIPs, 5mC, 5hmC, and 5fC but not 5caC strengthened binding to 8-mers containing CEBP half-site GC2AA (Figures 2–6 and Figure S2–S6 and S8). At C−1, 5mC, 5hmC, and 5fC inhibit binding while 5caC is bound similarly to cytosine for all five bZIP proteins. We also find several differences. dsDNA containing 5caC in some TRE (AP1)-like sequences, e.g., TGAC−1TAA, is better bound by Zta, ATF3|cJun, and cFos|cJun (Figures 5 and 6 and Figures S5 and S6). Finally, examination of ChIP-seq data indicates that many 8-mers that are well-bound by bZIP proteins when they contain modified cytosines are likely bound in vivo.
A possible structural explanation for similar binding to 5mC, 5hmC, and 5fC containing dsDNA at C2 by the different bZIP domains is that in all cases the methyl group of the conserved alanine can form a stabilizing hydrophobic interaction with the added carbon of these modifications. 5hmC and 5fC do not clash with the dsDNA. Some of these strongly bound 8-mers with 5hmC, 5fC, and 5caC are interesting structural targets for gaining more insight into sequence-specific dsDNA binding.
Previously, we discussed how 5mC and 5hmC change binding to dsDNA for CREB136 and Zta.37 5mC mimics the methyl group of thymine, particularly for binding CEBP half-site GC2AA. 5fC can be accommodated like 5hmC, while 5caC, which has a second bulky oxygen atom, clashes with both the protein and/or dsDNA depending on the rotamer.
An interesting aspect of our experimental approach is we can examine binding to 8-mers containing multiple modified cytosines. The presence of multiple modified cytosines in the same dsDNA sequence is less studied, and many of these sequences are novel. Modified cytosines are known to change the structure of dsDNA. 64–66 5fC alters dsDNA structure more than 5mC or 5hmC.27 These novel 8-mers may be interesting targets for further structural studies.
5caC strengthens the binding of Zta to the TRE more than the binding of CREB1 to the CRE.37 A structural difference between binding the CRE (T−4G−3A−2C−1G1T2C3A4) and the related TRE (T–4G–3A–2C/G0T2C3A4) is that a conserved arginine from each monomer binds a guanine at the center of the CRE dyad. In the case of the TRE, which is a deletion of a nucleotide at the center of the dyad, has one arginine in the major groove interacting with guanine while the arginine from the second monomer is out of the major groove and in the water.67 For the binding of CREB1 to a carboxylated CRE, there are steric conflicts with the added carboxylate groups at C−1. However, with rearrangement of the central arginines, one could argue that the structure is stabilized by a stabilizing salt bridge between the carboxylate and one of the arginines or both.36 With Zta binding the TRE (2C9N), there is more room in the center; however, the added carboxylate makes a serious conflict with the central arginine. Again, with some rearrangement of the side chain, this could become a stabilizing salt bridge. This may contribute to the different effects 5caC has on binding the TRE and CRE.
It will be interesting to expand this approach to additional TF families, as has been done previously for 5mC.31 A more complete analysis of additional TFs binding to modified dsDNA will help evaluate how widespread binding specificity changes occur.
Supplementary Material
Funding
This work is supported by the intramural research project of the National Cancer Institute, National Institutes of Health.
ABBREVIATIONS
- 5mC
5-methylcytosine
- 5hmC
5-hydroxymethylcytosine
- 5fC
5-formylcytosine
- 5caC
5-carboxylcytosine
- CREB1
cyclic AMP response element binding 1
- ATF3
activating transcription factor 3
- cJun and cFos
proto-oncogene
- dsDNA
double-stranded DNA
- PBM
protein binding microarray
- SNVs
single-nucleotide variants
Footnotes
The authors declare no competing financial interest.
ASSOCIATED CONTENT
Supporting Information
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.biochem.0c00475.
Figures S1–S12, Tables S1–S7 (PDF)
Contributor Information
Sreejana Ray, Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States.
Desiree Tillo, Laboratory of Metabolism and Cancer Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States.
Aniekanabasi Ufot, Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States.
Nima Assad, Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States.
Stewart Durell, Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States.
Charles Vinson, Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States.
REFERENCES
- (1).Ptashne M (1988) How eukaryotic transcriptional activators work. Nature 335, 683–689. [DOI] [PubMed] [Google Scholar]
- (2).Siggers T, and Gordan R (2014) Protein-DNA binding: complexities and multi-protein codes. Nucleic Acids Res. 42, 2099–2111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (3).Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, and Rao A (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930–935. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (4).Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, He C, and Zhang Y (2011) Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300–1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (5).Kohli RM, and Zhang Y (2013) TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502, 472–479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (6).He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, Ding J, Jia Y, Chen Z, Li L, Sun Y, Li X, Dai Q, Song CX, Zhang K, He C, and Xu GL (2011) Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303–1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (7).Song CX, Szulwach KE, Dai Q, Fu Y, Mao SQ, Lin L, Street C, Li Y, Poidevin M, Wu H, Gao J, Liu P, Li L, Xu GL, Jin P, and He C (2013) Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell 153, 678–691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (8).Booth MJ, Branco MR, Ficz G, Oxley D, Krueger F, Reik W, and Balasubramanian S (2012) Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 336, 934–937. [DOI] [PubMed] [Google Scholar]
- (9).Berney M, and McGouran JF (2018) Methods for detection of cytosine and thymine modifications in DNA, Nature Reviews. Chemistry 2, 332–348. [Google Scholar]
- (10).Neri F, Incarnato D, Krepelova A, Parlato C, and Oliviero S (2016) Methylation-assisted bisulfite sequencing to simultaneously map 5fC and 5caC on a genome-wide scale for DNA demethylation analysis. Nat. Protoc. 11, 1191–1205. [DOI] [PubMed] [Google Scholar]
- (11).Nanan KK, Sturgill DM, Prigge MF, Thenoz M, Dillman AA, Mandler MD, and Oberdoerffer S (2019) TETC-atalyzed 5-Carboxylcytosine Promotes CTCF Binding to Suboptimal Sequences Genome-wide. iScience 19, 326–339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (12).Wu X, and Zhang Y (2017) TET-mediated active DNA demethylation: mechanism, function and beyond. Nat. Rev. Genet. 18, 517–534. [DOI] [PubMed] [Google Scholar]
- (13).Ramsahoye BH, Biniszkiewicz D, Lyko F, Clark V, Bird AP, and Jaenisch R (2000) Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc. Natl. Acad. Sci. U. S. A. 97, 5237–5242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (14).Illingworth R, Kerr A, Desousa D, Jorgensen H, Ellis P, Stalker J, Jackson D, Clee C, Plumb R, Rogers J, Humphray S, Cox T, Langford C, and Bird A (2008) A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol. 6, e22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (15).Kriaucionis S, and Heintz N (2009) The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324, 929–930. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (16).Hahn MA, Szabo PE, and Pfeifer GP (2014) 5-Hydroxymethylcytosine: a stable or transient DNA modification? Genomics 104, 314–323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (17).Wossidlo M, Nakamura T, Lepikhov K, Marques CJ, Zakhartchenko V, Boiani M, Arand J, Nakano T, Reik W, and Walter J (2011) 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat. Commun. 2, 241. [DOI] [PubMed] [Google Scholar]
- (18).Thomson JP, Nestor CE, and Meehan RR (2015) 5-Hydroxymethylcytosine Profiling in Human DNA. Methods Mol. Biol. 1589, 89–98. [DOI] [PubMed] [Google Scholar]
- (19).Xia B, Han D, Lu X, Sun Z, Zhou A, Yin Q, Zeng H, Liu M, Jiang X, Xie W, He C, and Yi C (2015) Bisulfite-free, base-resolution analysis of 5-formylcytosine at the genome scale. Nat. Methods 12, 1047–1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (20).Booth MJ, Marsico G, Bachman M, Beraldi D, and Balasubramanian S (2014) Quantitative sequencing of 5-formylcytosine in DNA at single-base resolution. Nat. Chem. 6, 435–440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (21).Shen L, Wu H, Diep D, Yamaguchi S, D’Alessio AC, Fung HL, Zhang K, and Zhang Y (2013) Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics. Cell 153, 692–706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (22).Chatterjee R, He X, Huang D, FitzGerald P, Smith A, and Vinson C (2014) High-resolution genome-wide DNA methylation maps of mouse primary female dermal fibroblasts and keratinocytes. Epigenet. Chromatin 7, 35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (23).Mann IK, Chatterjee R, Zhao J, He X, Weirauch MT, Hughes TR, and Vinson C (2013) CG methylated microarrays identify a novel methylated sequence bound by the CEBPB|ATF4 heterodimer that is active in vivo. Genome Res. 23, 988–997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (24).Iurlaro M, Ficz G, Oxley D, Raiber EA, Bachman M, Booth MJ, Andrews S, Balasubramanian S, and Reik W (2013) A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation. Genome Biol. 14, R119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (25).Pfeifer GP, Szabo PE, and Song J (2020) Protein Interactions at Oxidized 5-Methylcytosine Bases. J. Mol. Biol. 432, 1718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (26).Thalhammer A, Hansen AS, El-Sagheer AH, Brown T, and Schofield CJ (2011) Hydroxylation of methylated CpG dinucleotides reverses stabilisation of DNA duplexes by cytosine 5-methylation. Chem. Commun. (Cambridge, U. K.) 47, 5325–5327. [DOI] [PubMed] [Google Scholar]
- (27).Raiber EA, Murat P, Chirgadze DY, Beraldi D, Luisi BF, and Balasubramanian S (2015) 5-Formylcytosine alters the structure of the DNA double helix. Nat. Struct. Mol. Biol. 22, 44–49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (28).Khund Sayeed S, Zhao J, Sathyanarayana BK, Golla JP, and Vinson C (2015) C/EBPbeta (CEBPB) protein binding to the C/EBP|CRE DNA 8-mer TTGC|GTCA is inhibited by 5hmC and enhanced by 5mC, 5fC, and 5caC in the CG dinucleotide. Biochim. Biophys. Acta, Gene Regul. Mech. 1849, 583–589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (29).Yang J, Horton JR, Li J, Huang Y, Zhang X, Blumenthal RM, and Cheng X (2019) Structural basis for preferential binding of human TCF4 to DNA containing 5-carboxylcytosine. Nucleic Acids Res. 47, 8375–8387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (30).Zhu H, Wang G, and Qian J (2016) Transcription factors as readers and effectors of DNA methylation. Nat. Rev. Genet. 17, 551–565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (31).Yin Y, Morgunova E, Jolma A, Kaasinen E, Sahu B, Khund-Sayeed S, Das PK, Kivioja T, Dave K, Zhong F, Nitta KR, Taipale M, Popov A, Ginno PA, Domcke S, Yan J, Schubeler D, Vinson C, and Taipale J (2017) Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science 356, eaaj2239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (32).Rishi V, Bhattacharya P, Chatterjee R, Rozenberg J, Zhao J, Glass K, Fitzgerald P, and Vinson C (2010) CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes. Proc. Natl. Acad. Sci. U. S. A. 107, 20311–20316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (33).Bahar Halpern K, Vana T, and Walker MD (2014) Paradoxical role of DNA methylation in activation of FoxA2 gene expression during endoderm development. J. Biol. Chem. 289, 23882–23892. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (34).Niesen MI, Osborne AR, Yang H, Rastogi S, Chellappan S, Cheng JQ, Boss JM, and Blanck G (2005) Activation of a methylated promoter mediated by a sequence-specific DNA-binding protein, RFX. J. Biol. Chem. 280, 38914–38922. [DOI] [PubMed] [Google Scholar]
- (35).Golla JP, Zhao J, Mann IK, Sayeed SK, Mandal A, Rose RB, and Vinson C (2014) Carboxylation of cytosine (5caC) in the CG dinucleotide in the E-box motif (CGCAG|GTG) increases binding of the Tcf3|Ascl1 helix-loop-helix heterodimer 10-fold. Biochem. Biophys. Res. Commun. 449, 248–255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (36).Syed KS, He X, Tillo D, Wang J, Durell SR, and Vinson C (2016) 5-Methylcytosine (5mC) and 5-Hydroxymethylcytosine (5hmC) Enhance the DNA Binding of CREB1 to the C/EBP Half-Site Tetranucleotide GCAA. Biochemistry 55, 6940–6948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (37).Tillo D, Ray S, Syed KS, Gaylor MR, He X, Wang J, Assad N, Durell SR, Porollo A, Weirauch MT, and Vinson C (2017) The Epstein-Barr Virus B-ZIP Protein Zta Recognizes Specific DNA Sequences Containing 5-Methylcytosine and 5-Hydroxymethylcytosine. Biochemistry 56, 6200–6210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (38).Khund-Sayeed S, He X, Holzberg T, Wang J, Rajagopal D, Upadhyay S, Durell SR, Mukherjee S, Weirauch MT, Rose R, and Vinson C (2016) 5-Hydroxymethylcytosine in E-box motifs ACAT|GTG and ACAC|GTG increases DNA-binding of the B-HLH transcription factor TCF4. Integr Biol. (Camb) 8, 936–945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (39).Kribelbauer JF, Lu XJ, Rohs R, Mann RS, and Bussemaker HJ (2020) Toward a Mechanistic Understanding of DNA Methylation Readout by Transcription Factors. J. Mol. Biol. 432, 1801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (40).Vinson C, Myakishev M, Acharya A, Mir AA, Moll JR, and Bonovich M (2002) Classification of human B-ZIP proteins based on dimerization properties. Mol. Cell. Biol. 22, 6321–6335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (41).Newman JR, and Keating AE (2003) Comprehensive identification of human bZIP interactions with coiled-coil arrays. Science 300, 2097–2101. [DOI] [PubMed] [Google Scholar]
- (42).Landschulz WH, Johnson PF, and McKnight SL (1988) The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240, 1759–1764. [DOI] [PubMed] [Google Scholar]
- (43).Vinson CR, Sigler PB, and McKnight SL (1989) Scissors-grip model for DNA recognition by a family of leucine zipper proteins. Science 246, 911–916. [DOI] [PubMed] [Google Scholar]
- (44).Krylov D, Mikhailenko I, and Vinson C (1994) A thermodynamic scale for leucine zipper stability and dimerization specificity: e and g interhelical interactions. EMBO J. 13, 2849–2861. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (45).Agre P, Johnson PF, and McKnight SL (1989) Cognate DNA binding specificity retained after leucine zipper exchange between GCN4 and C/EBP. Science 246, 922–926. [DOI] [PubMed] [Google Scholar]
- (46).Johnson PF (1993) Identification of C/EBP basic region residues involved in DNA sequence recognition and half-site spacing preference. Mol. Cell. Biol. 13, 6919–6930. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (47).Fujii Y, Shimizu T, Toda T, Yanagida M, and Hakoshima T (2000) Structural basis for the diversity of DNA recognition by bZIP transcription factors. Nat. Struct. Biol. 7, 889–893. [DOI] [PubMed] [Google Scholar]
- (48).Miller M (2009) The importance of being flexible: the case of basic region leucine zipper transcriptional regulators. Curr. Protein Pept. Sci. 10, 244–269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (49).Hong S, Wang D, Horton JR, Zhang X, Speck SH, Blumenthal RM, and Cheng X (2017) Methyl-dependent and spatial-specific DNA recognition by the orthologous transcription factors human AP-1 and Epstein-Barr virus Zta. Nucleic Acids Res. 45, 2503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (50).He X, Tillo D, Vierstra J, Syed KS, Deng C, Ray GJ, Stamatoyannopoulos J, FitzGerald PC, and Vinson C (2015) Methylated Cytosines Mutate to Transcription Factor Binding Sites that Drive Tetrapod Evolution. Genome Biol. Evol. 7, 3155–3169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (51).Ray S, Tillo D, Assad N, Ufot A, Deppmann C, Durell SR, Porollo A, and Vinson C (2018) Replacing C189 in the bZIP domain of Zta with S, T, V, or A changes DNA binding specificity to four types of double-stranded DNA. Biochem. Biophys. Res. Commun. 501, 905–912. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (52).Ray S, Ufot A, Assad N, Singh J, Durell SR, Porollo A, Tillo D, and Vinson C (2019) The bZIP mutant CEBPB (V285A) has sequence specific DNA binding propensities similar to CREB1. Biochim. Biophys. Acta, Gene Regul. Mech. 1862, 486–492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (53).Sharrocks AD (1994) A T7 expression vector for producing N- and C-terminal fusion proteins with glutathione S-transferase. Gene 138, 105–108. [DOI] [PubMed] [Google Scholar]
- (54).Badis G, Berger MF, Philippakis AA, Talukder S, Gehrke AR, Jaeger SA, Chan ET, Metzler G, Vedenko A, Chen X, Kuznetsov H, Wang CF, Coburn D, Newburger DE, Morris Q, Hughes TR, and Bulyk ML (2009) Diversity and complexity in DNA recognition by transcription factors. Science 324, 1720–1723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (55).Berger MF, and Bulyk ML (2009) Universal protein-binding microarrays for the comprehensive characterization of the DNA-binding specificities of transcription factors. Nat. Protoc. 4, 393–411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (56).Lam KN, van Bakel H, Cote AG, van der Ven A, and Hughes TR (2011) Sequence specificity is obtained from the majority of modular C2H2 zinc-finger arrays. Nucleic Acids Res. 39, 4680–4690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (57).The ENCODE Project Consortium (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (58).Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, Cheng C, Mu XJ, Khurana E, Rozowsky J, Alexander R, Min R, Alves P, Abyzov A, Addleman N, Bhardwaj N, Boyle AP, Cayting P, Charos A, Chen DZ, Cheng Y, Clarke D, Eastman C, Euskirchen G, Frietze S, Fu Y, Gertz J, Grubert F, Harmanci A, Jain P, Kasowski M, Lacroute P, Leng JJ, Lian J, Monahan H, O’Geen H, Ouyang Z, Partridge EC, Patacsil D, Pauli F, Raha D, Ramirez L, Reddy TE, Reed B, Shi M, Slifer T, Wang J, Wu L, Yang X, Yip KY, Zilberman-Schapira G, Batzoglou S, Sidow A, Farnham PJ, Myers RM, Weissman SM, and Snyder M (2012) Architecture of the human regulatory network derived from ENCODE data. Nature 489, 91–100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (59).Ramasubramanyan S, Kanhere A, Osborn K, Flower K, Jenner RG, and Sinclair AJ (2012) Genome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile. J. Virol 86, 12494–12502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (60).Laos R, Thomson JM, and Benner SA (2014) DNA polymerases engineered by directed evolution to incorporate nonstandard nucleotides. Front. Microbiol. 5, 565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (61).Chen CC, Wang KY, and Shen CK (2012) The mammalian de novo DNA methyltransferases DNMT3A and DNMT3B are also DNA 5-hydroxymethylcytosine dehydroxymethylases. J. Biol. Chem. 287, 33116–33121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (62).Oba R, Kudo Y, Sato N, Noda R, and Otsuka Y (2006) A new method of competitive reverse transcription polymerase chain reaction with SYBR Gold staining for quantitative analysis of mRNA. Electrophoresis 27, 2865–2868. [DOI] [PubMed] [Google Scholar]
- (63).Zipper H, Brunner H, Bernhagen J, and Vitzthum F (2004) Investigations on DNA intercalation and surface binding by SYBR Green I, its structure determination and methodological implications. Nucleic Acids Res. 32, e103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (64).Renciuk D, Blacque O, Vorlickova M, and Spingler B (2013) Crystal structures of B-DNA dodecamer containing the epigenetic modifications 5-hydroxymethylcytosine or 5-methylcytosine. Nucleic Acids Res. 41, 9891–9900. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (65).Szulik MW, Pallan PS, Nocek B, Voehler M, Banerjee S, Brooks S, Joachimiak A, Egli M, Eichman BF, and Stone MP (2015) Correction to differential stabilities and sequence-dependent base pair opening dynamics of watson-crick base pairs with 5-hydroxymethylcytosine, 5-formylcytosine, or 5-carboxylcytosine. Biochemistry 54, 2550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (66).Szulik MW, Pallan PS, Nocek B, Voehler M, Banerjee S, Brook S, Joachimiak A, Egli M, Eichman BF, and Stone MP (2015) Differential stabilities and sequence-dependent base pair opening dynamics of Watson-Crick base pairs with 5-hydroxymethylcytosine, 5-formylcytosine, or 5-carboxylcytosine. Biochemistry 54, 1294–1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (67).Glover JN, and Harrison SC (1995) Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature 373, 257–261. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

